Arman Oruc has joined Goodwin as a partner in its antitrust and competition practice in Los Angeles. The firm in April added another antitrust partner, Andrew Lacy. Both partners focus on transactions and litigation. Read the Reuters announcement here.
Related Content
- InsightApril 24, 2024
European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy
- InsightDecember 27, 2023
Antitrust & Competition Technology Quarterly Update Q3 2023
- InsightOctober 23, 2023
Antitrust & Competition Life Sciences Quarterly Update Q3 2023
- InsightAugust 24, 2023
Antitrust & Competition Technology Quarterly Update Q2 2023
- InsightAugust 11, 2023
Antitrust & Competition Life Sciences Quarterly Update Q2 2023
- InsightAugust 11, 2023
Antitrust & Competition Healthcare Quarterly Update Q2 2023
- InsightJune 14, 2023
Antitrust & Competition Technology Quarterly Update Q1 2023
- InsightMay 22, 2023
Antitrust & Competition Healthcare Quarterly Update Q1 2023
- Speaking EngagementsMay 3, 2024 | 9:05 AM - 9:45 AM PT
Informa Connect Antitrust West Coast 2024 Conference
- Press ReleaseMay 2, 2024
Mariana Oncology To Be Acquired by Novartis For $1 Billion Upfront, And Up To $750 Million in Milestones
- Press ReleaseApril 29, 2024
Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion
- WebinarJanuary 16, 2024
Goodwin CLE Days 2024
- Press ReleaseJanuary 11, 2024
Renesas to Acquire Transphorm in $339 Million Transaction
- Press ReleaseJanuary 10, 2024
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Press ReleaseJanuary 8, 2024
Harpoon Therapeutics To Be Acquired by Merck for $680 Million
- Press Release5 January 2024
Stirling Square, TA and Macquarie Capital, through Giant BidCo, announce a recommended public cash offer of SEK 46 to the shareholders of Byggfakta